Effectiveness of Telerehabilitation on Scleroderma
Investigation of the Effectiveness of Telerehabilitation on Individuals With Hand-Affected Scleroderma
1 other identifier
interventional
32
1 country
1
Brief Summary
The effects of exercises performed by telerehabilitation on individuals with hand-affected scleroderma on range of motion, grip strength, function, sensation, daily life activities and general health will be compared with the effects of traditional physiotherapy practices.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 23, 2020
CompletedFirst Posted
Study publicly available on registry
September 24, 2020
CompletedStudy Start
First participant enrolled
May 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2023
CompletedApril 13, 2022
April 1, 2022
1.5 years
September 23, 2020
April 12, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Hand Mobility in Scleroderma (HAMIS)
Hand Mobility in Scleroderma is a hand function test developed for adults who have systemic sclerosis. HAMIS consists of 9 items designed to measure all movements assessed in an ordinary range of motion-measured hand test. Each item is graded on a 0-3 scale, where 0 corresponds to normal function and 3 denotes that the individual is unable to perform the item. Each hand is assessed separately. The total score of HAMIS for each hand is 370 Sandqvist and Eklund Vol. 13, No. 6, December 2000 27, which represents a high degree of dysfunction.
change from baseline at 8 weeks
Secondary Outcomes (4)
9-Hole Peg Test
change from baseline at 8 weeks
Scleroderma Health Assessment Questionnaire (SHAQ)
change from baseline at 8 weeks
Semmes Weinstein Monofilaman Test
change from baseline at 8 weeks
Pittsburgh Sleep Quality Index (PSQI)
change from baseline at 8 weeks
Study Arms (2)
Telerehabilitation
EXPERIMENTALStretching and strengthening exercises, functional exercises, massage techniques, sensory training and breathing exercises will be applied to the patients via telerehabilitation for 3 sessions per week.
Rehabilitation by Physiotherapist in the Clinic
EXPERIMENTALStretching and strengthening exercises, functional exercises, massage techniques, sensory training and breathing exercises will be applied to the patients by physiotherapist in the clinic for 3 sessions per week.
Interventions
stretching exercises; all finger joints, wrist and supination-pronation direction strengthening exercises; finger and wrist functional exercises retrograde massage; starting from the distal phalanx to the elbow sensory education; desentilation training (cotton…) breathing exercises 5 days / week, 8 weeks in total * 3 days / week with physiotherapist * 2 days / week as home program 30 minutes / day 12 repetitions
stretching exercises; all finger joints, wrist and supination-pronation direction strengthening exercises; finger and wrist functional exercises retrograde massage; starting from the distal phalanx to the elbow sensory education; desentilation training (cotton…) breathing exercises 5 days / week, 8 weeks in total * 3 days / week with physiotherapist * 2 days / week as home program 30 minutes / day 12 repetitions
Eligibility Criteria
You may qualify if:
- Having been diagnosed with scleroderma
- Stability of medical treatments
- To be able to adapt to the exercises
You may not qualify if:
- The patient has a history of neurological disease or trauma that may affect his symptoms
- Systemic involvement that affects the treatment process
- Being in the active phase of the disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tugba Civi Karaaslan
Istanbul, Buyukcekmece, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
TUGBA CIVI KARAASLAN, PhD (c)
Research Assistant
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Assistant
Study Record Dates
First Submitted
September 23, 2020
First Posted
September 24, 2020
Study Start
May 1, 2022
Primary Completion
November 1, 2023
Study Completion
December 30, 2023
Last Updated
April 13, 2022
Record last verified: 2022-04
Data Sharing
- IPD Sharing
- Will not share